Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

After spending years developing its endoscopic device treatment for patients with Type 2 diabetes, Fractyl Health is now ...

Biotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Scientists have discovered that the Brazilian camu-camu berry, already known for its health benefits in fighting obesity and ...

🚨NEW DRUG TO REGROW TEETH ENTERS HUMAN TRIALS Japanese researchers developed a drug to regrow teeth, set to begin human ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...